+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 35Years - 89Years
All Genders
ID05968898

Evaluating a Radiomics-Based AI Tool to Help Doctors Assess Lung Nodules for Cancer Risk in Adults Aged 35 to 89

Led by Abramson Cancer Center at Penn Medicine · Updated on 2026-06-02

300

Participants Needed

3

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a radiomics-based computer-aided diagnosis CAD tool to help doctors manage pulmonary nodules PNs compared to usual care. This pragmatic clinical trial involves adults aged 35 to 89 years who have PNs measuring 8 to 30mm. The goal is to improve the accuracy of malignancy risk assessment for these nodules, which is important to diagnose lung cancer early and avoid unnecessary procedures. The study is sponsored by Abramson Cancer Center at Penn Medicine.

CONDITIONS

Brief Title

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Research Team

R

Roger Y. Kim, MD, MSCE

A

Anil Vachani, MD, MSCE

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here